by | Jun 24, 2025 | Lupus Foundation of America
The Lupus Foundation of America continues to lead advocacy efforts to protect and strengthen funding for the National Institutes of Health (NIH), which is the largest funder of lupus research. Recently, we joined with 100 patient, research and health professional...
by | Jun 20, 2025 | Lupus Foundation of America, News & Events
Researchers from EMD Serono and global collaborators shared promising results from Cohort B of the phase II trial of the WILLOW study, evaluating the safety and efficacy of enpatoran, a first-in-class oral toll-like receptor 7 and 8 (TLR7/8) inhibitor, in people with...
by | Jun 6, 2025 | Lupus Foundation of America, News & Events
Cullinan Therapeutics has announced a licensing agreement with Genrix Bio for global rights to velinotamig, a clinical-stage BCMAxCD3 bispecific T cell engager. The agreement allows Cullinan to explore the development of the therapy in autoimmune diseases, like lupus....
by | Jun 5, 2025 | Lupus Foundation of America
The Lupus Foundation of America is proud to announce the seven recipients of the 2025 Gina M. Finzi Memorial Student Summer Fellowship Program (Finzi). This program supports undergraduate, graduate, and medical students conducting lupus-focused research under the...
by | May 27, 2025 | Lupus Foundation of America
This June, we recognize Men’s Health Month by honoring the strength, challenges and lived experiences of men with lupus. Lupus is often overlooked and misunderstood in men – leading to stigma, delayed diagnoses and a lack of tailored support. By highlighting the...
by | May 21, 2025 | Lupus Foundation of America
In a new study, researchers identified eight disease activity domains for further development into the new Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE), a clinical trial outcome assessment (COA) for systemic lupus erythematosus (SLE)...
